BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32867573)

  • 1. 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.
    Podszun MC; Chung JY; Ylaya K; Kleiner DE; Hewitt SM; Rotman Y
    J Histochem Cytochem; 2020 Sep; 68(9):635-643. PubMed ID: 32867573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects.
    Torquato P; Bartolini D; Giusepponi D; Piroddi M; Sebastiani B; Saluti G; Galarini R; Galli F
    Free Radic Biol Med; 2019 Feb; 131():115-125. PubMed ID: 30508576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis.
    Kawamura K; Kobayashi Y; Kageyama F; Kawasaki T; Nagasawa M; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Dec; 95(12):3596-601. PubMed ID: 11151898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization.
    Hartley DP; Kolaja KL; Reichard J; Petersen DR
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):23-33. PubMed ID: 10558920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
    Seki S; Kitada T; Yamada T; Sakaguchi H; Nakatani K; Wakasa K
    J Hepatol; 2002 Jul; 37(1):56-62. PubMed ID: 12076862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts.
    Rohn TT; Nelson LK; Waeg G; Quinn MT
    Biochem Pharmacol; 1998 Nov; 56(10):1371-9. PubMed ID: 9825737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases.
    Ohhira M; Ohtake T; Matsumoto A; Saito H; Ikuta K; Fujimoto Y; Ono M; Toyokuni S; Kohgo Y
    Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):145S-149S. PubMed ID: 9622393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin E on lipid peroxidation in healthy persons.
    Meagher EA; Barry OP; Lawson JA; Rokach J; FitzGerald GA
    JAMA; 2001 Mar; 285(9):1178-82. PubMed ID: 11231747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
    Hartley DP; Kroll DJ; Petersen DR
    Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
    Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
    Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
    Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ detection of lipid peroxidation by-products in chronic liver diseases.
    Paradis V; Kollinger M; Fabre M; Holstege A; Poynard T; Bedossa P
    Hepatology; 1997 Jul; 26(1):135-42. PubMed ID: 9214462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes.
    Blanc EM; Keller JN; Fernandez S; Mattson MP
    Glia; 1998 Feb; 22(2):149-60. PubMed ID: 9537835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.
    Kanuri G; Ladurner R; Skibovskaya J; Spruss A; Königsrainer A; Bischoff SC; Bergheim I
    Liver Int; 2015 Feb; 35(2):562-8. PubMed ID: 24351080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells.
    Parola M; Pinzani M; Casini A; Albano E; Poli G; Gentilini A; Gentilini P; Dianzani MU
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1044-50. PubMed ID: 8352762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology.
    Comporti M
    Free Radic Res; 1998 Jun; 28(6):623-35. PubMed ID: 9736314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.
    Aleynik SI; Leo MA; Aleynik MK; Lieber CS
    Alcohol Clin Exp Res; 1998 Feb; 22(1):192-6. PubMed ID: 9514306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation-dependent and -independent protein thiol modifications in isolated rat hepatocytes: differential effects of vitamin E and disulfiram.
    Dogterom P; Mulder GJ; Nagelkerke JF
    Chem Biol Interact; 1989; 71(2-3):291-306. PubMed ID: 2598304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease.
    Podszun MC; Frank J
    Redox Biol; 2021 Jun; 42():101937. PubMed ID: 33773953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.